Evidence map›Paper›PMID 24604326›Full record

ArticleAnalytical and bioanalytical chemistry2014

An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.

Brooke G Pantazides, Caroline M Watson, Melissa D Carter, Brian S Crow, Jonas W Perez, Thomas A Blake, Jerry D Thomas, Rudolph C Johnson

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Purification of recombinant human butyrylcholinesterase on Hupresin®.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Characterization of butyrylcholinesterase in bovine serum.Chemico-biological interactions · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Brooke G PantazidesDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Atlanta, GA, 30341, USA.
Caroline M Watson
Melissa D Carter
Brian S Crow
Jonas W Perez
Thomas A Blake
Jerry D Thomas
Rudolph C Johnson
National Center for Environmental Health · USBattelle · USThe Centers · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Organophosphorus nerve agent (OPNA) adducts to butyrylcholinesterase (BChE) can be used to confirm exposure in humans. A highly accurate method to detect G- and V-series OPNA adducts to BChE in 75 μL of filtered blood, serum, or plasma has been developed using immunomagnetic separation (IMS) coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS). The reported IMS method captures > 88 % of the BChE in a specimen and corrects for matrix effects on peptide calibrators. The optimized method has been used to quantify baseline BChE levels (unadducted and OPNA-adducted) in a matched-set of serum, plasma, and whole blood (later processed in-house for plasma content) from 192 unexposed individuals to determine the interchangeability of the tested matrices. The results of these measurements demonstrate the ability to accurately measure BChE regardless of the format of the blood specimen received. Criteria for accepting or denying specimens were established through a series of sample stability and processing experiments. The results of these efforts are an optimized and rugged method that is transferrable to other laboratories and an increased understanding of the BChE biomarker in matrix.

Indexed as

Biological AssayAntibodies, MonoclonalButyrylcholinesteraseChemical Warfare AgentsChromatography, LiquidHumansImmunomagnetic SeparationIn Vitro TechniquesOrganothiophosphorus CompoundsSarinTandem Mass SpectrometryAntibodies, MonoclonalButyrylcholinesteraseChemical Warfare AgentsOrganothiophosphorus CompoundsSarinVX-agent

Identifiers

PMID24604326
PMCPMC4836380
OpenAlexW1975020331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.